The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
Open accessAbstract
The therapeutic efficacy of systemic drug delivery vehicles depends on their ability to evade the immune system, cross the biological barriers of the body and localize at target tissues. Leukocytes possess all of these functions and exert their targeting ability through cellular membrane interactions. Here we show that NanoPorous Silicon particles (NPS) can successfully perform all these actions when coated with cellular membranes purified from white blood cells. These hybrid particles called LeukoLike Vectors (LLV) were able to: prevent rapid clearance of phagocytic cells of the immune system; communicate with endothelial cells through receptor-ligand interaction; transport and release a payload across an inflamed reconstructed endothelium. Furthermore, LLV retained their functions when injected in vivo, showing enhanced circulation time and improved accumulation in the tumour.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Yang, L., Froio, R. M., Sciuto, T. E., Dvorak, A. M., Alon, R., & Luscinskas, F. W. (2005) · Blood · doi:10.1182/blood-2004-12-4942 · Cited by 721
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
Self-citationMulti-targeted therapy of cancer by genistein
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.052 · Cited by 620
Barreiro, O., Yáñez-Mó, M., Serrador, J. M., Montoya, M. C., Vicente-Manzanares, M., Tejedor, R., Furthmayr, H., & Sánchez-Madrid, F. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112126 · Cited by 594
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Nanoparticles that communicate in vivo to amplify tumour targeting
Park, J., Lin, K., Singh, N., Schwöppe, C., Mesters, R. M., Berdel, W. E., Ruoslahti, E. I., Sailor, M. J., von Maltzhan, G., & Bhatia, S. N. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 500
Millán, J., Hewlett, L., Glyn, M., Toomre, D., Clark, P., & Ridley, A. J. (2006) · Nature Cell Biology · doi:10.1038/ncb1356 · Cited by 414
Ananta, J. S., Godin, B., Sethi, R., Moriggi, L., Liu, X., Serda, R. E., Krishnamurthy, R., Muthupillai, R., Bolskar, R. D., Helm, L., et al. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.203 · Cited by 409
Self-citationCampbell, R. B., Fukumura, D., Brown, E. B., Mazzola, L. M., Izumi, Y., Jain, R. K., Torchilin, V. P., & Munn, L. L. (2002) · PubMed · Cited by 372
Trickler, W. J., Lantz, S. M., Murdock, R. C., Schrand, A. M., Robinson, B. L., Newport, G. D., Schlager, J. J., Oldenburg, S. J., Paule, M. G., Slikker, W., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq244 · Cited by 346
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin, S., Nehoff, H., & Greish, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.013 · Cited by 309
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging☆
MANCHESTER, M., & SINGH, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.014 · Cited by 292
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Self-citationvan Vliet, S. J., Gringhuis, S. I., Geijtenbeek, T. B. H., & van Kooyk, Y. (2006) · Nature Immunology · doi:10.1038/ni1390 · Cited by 216
Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics
Godin, B., Tasciotti, E., Liu, X., Serda, R. E., & Ferrari, M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200077p · Cited by 211
Self-citationDrug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers
M. Rabanel, J., Aoun, V., Elkin, I., Mokhtar, M., & Hildgen, P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784702 · Cited by 205
Mechanisms for transcellular diapedesis: probing and pathfinding by `invadosome-like protrusions'
Carman, C. V. (2009) · Journal of Cell Science · doi:10.1242/jcs.047522 · Cited by 198
van de Ven, A. L., Kim, P., Haley, O., Fakhoury, J. R., Adriani, G., Schmulen, J., Moloney, P., Hussain, F., Ferrari, M., Liu, X., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.021 · Cited by 188
Self-citationNanotechnology for breast cancer therapy
Tanaka, T., Decuzzi, P., Cristofanilli, M., Sakamoto, J. H., Tasciotti, E., Robertson, F. M., & Mauro Ferrari, B. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9209-0 · Cited by 181
Self-citationWhat does physics have to do with cancer?
Michor, F., Liphardt, J., Ferrari, M., & Widom, J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3092 · Cited by 176
Self-citationTailored Porous Silicon Microparticles: Fabrication and Properties
Chiappini, C., Tasciotti, E., Fakhoury, J. R., Fine, D., Pullan, L., Wang, Y., Fu, L., Liu, X., & Ferrari, M. (2010) · ChemPhysChem · doi:10.1002/cphc.200900914 · Cited by 170
Self-citationSphingomyelin and Cholesterol: From Membrane Biophysics and Rafts to Potential Medical Applications
Barenholz, Y. (2004) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4757-5806-1_5 · Cited by 159
Long Circulating Liposomes: Old Drugs, New Therapeutics
Woodle, M. C., & Storm, G. (1998) · Springer eBooks · doi:10.1007/978-3-662-22115-0 · Cited by 137
E‐Selectin‐Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow
Mann, A. P., Tanaka, T., Somasunderam, A., Liu, X., Gorenstein, D. G., & Mauro Ferrari, B. (2011) · Advanced Materials · doi:10.1002/adma.201101541 · Cited by 125
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Moghimi, S. M., & Davis, S. S. (1994) · PubMed · Cited by 104
van de Ven, A. L., Wu, M., Lowengrub, J. S., McDougall, S. R., Chaplain, M. A. J., Vittorio Cristini, C., Mauro Ferrari, B., & Frieboes, H. B. (2012) · AIP Advances · doi:10.1063/1.3699060 · Cited by 98
Cooperative, Nanoparticle‐Enabled Thermal Therapy of Breast Cancer
Shen, H., You, J., Zhang, G., Žiemys, A., Li, Q., Bai, L., Deng, X., Erm, D. R., Liu, X., Li, C., et al. (2011) · Advanced Healthcare Materials · doi:10.1002/adhm.201100005 · Cited by 96
Mitotic trafficking of silicon microparticles
Serda, R. E., Ferrati, S., Godin, B., et al. (2009) · Nanoscale · doi:10.1039/b9nr00138g · Cited by 88
Cho, Y. I., Park, S., Jeong, S. Y., & Yoo, H. S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.010 · Cited by 72
Intracellular trafficking of silicon particles and logic-embedded vectors
Ferrati, S., Mack, A. A., Chiappini, C., Liu, X., Bean, A. J., Mauro Ferrari, B., & Serda, R. E. (2010) · Nanoscale · doi:10.1039/c0nr00227e · Cited by 72
Self-citationNew aspects of the molecular constituents of tissue barriers
Bauer, H., Traweger, A., Zweimueller-Mayer, J., Lehner, C., Tempfer, H., Krizbai, I. A., Wilhelm, I., & Bauer, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0484-6 · Cited by 60
Dalgleish, A. G. (2010) · Cited by 51
Cited by
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Metadata
- Authors
- Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., Isenhart, L., Ferrari, M., & Tasciotti, E.
- Venue
- Nature Nanotechnology
- Published
- 2012-12-16
- Volume
- 8
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- OpenAlex
- W1980052502
- Cited by
- 1,168
- References
- 50
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.